Faculty Summaries
Mary B Daly, MD, PhD
Mary B. Daly, MD, PhD
Professor
  • Chair, Department of Clinical Genetics
  • Timothy R. Talbot Jr. Chair for Cancer Research

Selected Publications

  • Montgomery, S.V., Barsevick, A.M., Egleston, B.L., Bingler, R., Ruth, K., Miller, S.M., Malick, J., Cescon, T.P., Daly, M.B. "Preparing Individuals to Communicate Genetic Test Results to Their Relatives: Report of a Randomized Control Trial," Familial Cancer 2013 Feb 19, DOI: 10.1007/s10689-013-9609-z [epub ahead of print] (PMCID: PMC370656).
  • Bradbury, A.R., Patrick-Miller, L., Egleston, B.L., Schwartz, L.A., Sands, C.B., Shorter, R., Moore, C.W., Tuchman, L., Rauch, P., Malhotra, S., Rowan, B., Van Decker, S., Schmidheiser, H., Bealin, L., Sicilia, P., Daly, M.B.  "Knowledge and Perceptions of Familial and Genetic Risks for Breast Cancer Risk in Adolescent Girls," Breast Cancer Res Treat 136(3):749-757, 2012. (PMCID: PMC3513641).
  • Cherry, C, Ropka, M., Lyle, J., Napolitano, L., Daly, M.B. "Understanding the Needs of Women Considering Risk Reducing Salpingo-Oophorectomy," Cancer Nursing 36(3):E33-8, 2013. (PMCID: PMC3637391).
  • Meropol, N.J., Daly, M.B., Vig, H.S., Manion, F.J., Manne, S.L., Mazar, C., Murphy, C., Solarino, N., Zubarev, V.  "Delivery of Internet-based Cancer Genetic Counseling Services to Patients’ Homes: a Feasibility Study," Journal of Telemedicine and Telecare 17(1):36-40, 2011. (PMCID: PMC3263376).
  • Bradbury, A., Patrick-Miller, L., Fetzer, D., Egleston, B., Cummings, S., Forman, A., Bealin, L., Peterson, C., Corbman, M., O’Connell, J., Daly, M.  "Genetic Counselor Opinions of, and Experiences with Telephone Communication of BRCA1/2 Test Results," Clinical Genetics 79(2):125-131, 2011 (PMCID: PMC3059740).
  • Whittemore, A.S., Stearman, B., Venne, V., Halpern, J., Felberg, A., McGuire, V., Daly, M., Buys, S.S.  "No Evidence of Familial Correlation in Breast Cancer Metastasis," Breast Cancer Res. Treat. 118(3):575-581, 2009. (PMCID: PMC2783315).
  • Daly, M.B.  "The Impact of Social Roles on the Experience of Men in BRCA1/2 Families: Implications for Counseling," Journal of Genetic Counseling, 18(1):42-48, 2009. (PMCID: PMC2629810).
  • Barsevick, A.M., Montgomery, S.V., Ruth, K., Ross, E.A., Egleston, B.L., Bingler, R., Malick, J., Miller, S.M., Cescon, T.P., Daly, M.B.  "Intention to Communicate BRCA1/BRCA2 Genetic Test Results to the Family," J Fam Psychol 22(2):303-312, 2008. (Accepted prior to April 7, 2008).
Top

2013

  • Teo, Z.L., Provenzano, E., Dite, G.S., Park, D.J., Apicella, C., Sawyer, S.D., James, P.A., Mitchell, G., Trainer, A.H., Lindeman, G.J., Shackleton, K., Cicciarelli, L.; kConFab, Buys, S.S., Andrulis, I.L., Mulligan, A.M., Glendon, G., John, E.M., Terry, M.B., Daly, M., Odefrey, F.A., Nguyen-Dumont, T., Giles, G.G., Dowty, J.G., Winship, I., Goldgar, D.E. “Tumour Morphology Predicts PALB2 germline mutation status,” Br J Cancer 109(1):154-163, 2013. (PMCID: PMC3708559).
  • Couch, F.J., Wang, X., McGuffog, L., Lee, A., Olswold, C., Kuchenbaecker, K.B., Soucy, P., Fredericksen, Z., Barrowdale, D., Dennis, J., Gaudet, M.M., Dicks, E., Kosel, M., Healey, S., Sinilnikova, O.M., Lee, A., Bacot, F., Vincent, D., Hogervorst, F.B., Peock, S., Stoppa-Lyonnet, D., Jakubowska, A.; kConFab Investigators, Radice, P., Schmutzler, R.K.; SWE-BRCA, Domchek, S.M., Piedmonte, M., Singer, C.F., Friedman, E., Thomassen, M. Ontario Cancer Genetics Network, Hansen, T.V., Neuhausen, S.L., Szabo, C.I., Blanco, I., Greene, M.H., Karlan, B.Y., Garber, J., Phelan, C.M.,, Weitzel, J.N., Montagna, M., Olah, E., Andrulis, I.L., Godwin, A.K., Yannoukakos, D., Goldgar, D.E., Caldes, T., Nevanlinna, H., Osorio, A., Terry, M.B., Daly, M.B., van Rensburg, E.J., Hamann, U., Ramus, S.J., Toland, A.E., Caligo, M.A., Olopade, O.I., Tung, N., Claes, K., Beattie, M.S., Southey, M.C., Imyanitov, E.N., Tischkowitz, M., Janavicius, R., John, E.M., Kwong, A., Diez, O., Balmaña, J., Barkardottir, R.B., Arun, B.K., Rennert, G., Teo, S.H., Ganz, P.A., Campbell, I., van der Hout, A.H., van Deurzen, C.H., Seynaeve ,C., Gómez Garcia, E.B., van Leeuwen, F.E., Meijers-Heijboer, H.E., Gille, J.J., Ausems, M.G., Blok, M.J., Ligtenberg, M.J., Rookus, M.A., Devilee, P., Verhoef, S., van Os, T.A., Wijnen, J.T.; HEBON; EMBRACE, Frost, D., Ellis, S., Fineberg, E., Platte, R., Evans, D.G., Izatt, L., Eeles, R.A., Adlard, J., Eccles, D.M., Cook, J., Brewer, C., Douglas, F., Hodgson, S., Morrison, P.J., Side, L.E., Donaldson, A., Houghton, C., Rogers, M.T., Dorkins, H., Eason, J., Gregory, H., McCann, E., Murray, A., Calender, A., Hardouin, A., Berthet, P., Delnatte, C., Nogues, C., Lasset, C., Houdayer, C., Leroux, D., Rouleau, E., Prieur, F., Damiola, F., Sobol, H., Coupier, I., Venat-Bouvet, L., Castera, L., Gauthier-Villars, M., Léoné, M., Pujol, P., Mazoyer, S., Bignon, Y.J.; GEMO Study Collaborators, Złowocka-Perłowska, E., Gronwald, J., Lubinski, J., Durda, K., Jaworska, K., Huzarski, T., Spurdle, A.B., Viel, A., Peissel, B., Bonanni, B., Melloni, G., Ottini, L., Papi, L., Varesco, L., Tibiletti, M.G., Peterlongo, P., Volorio, S., Manoukian, S., Pensotti, V., Arnold, N., Engel, C., Deissler, H., Gadzicki, D., Gehrig, A., Kast, K., Rhiem, K., Meindl, A., Niederacher, D., Ditsch, N., Plendl, H., Preisler-Adams, S., Engert, S., Sutter, C., Varon-Mateeva, R., Wappenschmidt, B., Weber, B.H., Arver, B., Stenmark-Askmalm, M., Loman, N., Rosenquist, R., Einbeigi, Z., Nathanson, K.L., Rebbeck, T.R., Blank, S.V., Cohn, D.E., Rodriguez, G.C., Small, L., Friedlander, M., Bae-Jump, V.L., Fink-Retter, A., Rappaport, C., Gschwantler-Kaulich, D., Pfeiler, G., Tea, M.K., Lindor, N.M., Kaufman, B., Shimon Paluch, S., Laitman, Y., Skytte, A.B., Gerdes, A.M., Pedersen, I.S., Moeller, S.T., Kruse, T.A., Jensen, U.B., Vijai, J., Sarrel, K., Robson, M., Kauff, N., Mulligan, A.M., Glendon, G., Ozcelik, H., Ejlertsen, B., Nielsen, F.C., Jønson, L., Andersen, M.K., Ding, Y.C., Steele, L., Foretova, L., Teulé, A., Lazaro, C., Brunet, J., Pujana, M.A., Mai, P.L., Loud, J.T., Walsh, C., Lester, J., Orsulic, S., Narod, S.A., Herzog, J., Sand, S.R., Tognazzo, S., Agata, S., Vaszko, T., Weaver, J., Stavropoulou, A.V., Buys, S.S., Romero, A., de la Hoya, M., Aittomäki, K., Muranen, T.A., Duran, M., Chung, W.K., Lasa, A., Dorfling, C.M., Miron, A.; BCFR, Benitez, J., Senter, L., Huo, D., Chan, S.B., Sokolenko, A.P., Chiquette, J., Tihomirova, L., Friebel, T.M., Agnarsson, B.A., Lu, K.H., Lejbkowicz, F., James, P.A., Hall, P., Dunning, A.M., Tessier, D., Cunningham, J., Slager, S.L., Wang, C., Hart, S., Stevens, K., Simard, J., Pastinen, T., Pankratz, V.S., Offit, K., Easton, D.F., Chenevix-Trench, G., Antoniou, A.C.; CIMBA.  “Genome-wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk,” PLoS Genet. 2013;9(3):e1003212. doi: 10.1371/journal.pgen.1003212. Epub 2013 Mar 27. (PMCID: PMC3609646)
  • Mocci, E., Milne, R.L., Yuste Mendez-Villamil, E., Hopper, J.L., John, E.M., Andrulis, I.L., Chung, W.K., Daly, M.B., Buys, S.S., Malats, N., Goldgar, D.E. “Risk of Pancreatic Cancer in Breast Cancer Families from the Breast Cancer Family Registry,” Cancer Epidemiol Biomarkers Prev 22(5):803-811, 2013.
  • Montgomery, S.V., Barsevick, A.M., Egleston, B.L., Bingler, R., Ruth, K., Miller, S.M., Malick, J., Cescon, T.P., Daly, M.B. “Preparing Individuals to Communicate Genetic Test Results to Their Relatives: Report of a Randomized Control Trial,” Familial Cancer 2013 Feb 19, DOI: 10.1007/s10689-013-9609-z [epub ahead of print] (PMCID: PMC370656).
  • Rinella, E.S., Shao, Y., Yackowski, L., Pramanik, S., Oratz, R., Schnabel, F., Guha, S., LeDuc, C., Campell, C.L., Klugman, S.D., Terry, M.B., Senie, R.T., Andrulis, I.L., Daly, M., John, E.M., Roses, D., Chung, W.K., Ostrer, H.  “Genetic Variants Associated with Breast Cancer Risk for Ashkenazi Jewish Women with Strong Family Histories but No Identifiable BRCA1/2 Mutation,” Hum Genet 132(5):523-536, 2013.
  • Zhang, F.F., John, E.M., Knight, J.A., Kaur, M., Daly, M., Buys, S., Andrulis, I.L., Stearman, B., West, D., Terry, M.B. “Total Energy Intake and Breast Cancer Risk in Sisters: the Breast Cancer Family Registry,” Breast Cancer Research and Treatment 137(3):541-551, 2013.
  • Jiang, Z., Zhou, Y., Devarajan, K., Slater, C.M., Daly, M.B., Chen, X.  “Identifying Putative Breast Cancer-Associated Long Intergenic Non-Coding RNA Loci by High Density SNP Array Analysis,” Frontiers in Genetics 3:299, 2012. (PMCID: PMC3528021).
  • Urban, N., Thorpe, J., Karlan, B.Y., McIntosh, M.W., Palomares, M.R., Daly, M.B., Paley, P., Drescher, C.W. “Interpretation of Single and Serial Measures of HE4 and CA125 in Asymptomatic Women at High Risk for Ovarian Cancer,” Cancer Epidemiol Biomarkers Prev 21(11):2087-94, 2012. (PMCID: PMC3493821).
  • Gao, C., Devarajan, K., Zhou, Y., Slater, C.M., Daly, M.B., Chen, X. “Identifying Breast Cancer Risk Loci by Global Differential Allele-Specific Expression (DASE) Analysis in Mammary Epithelial Transcriptome,” BMC Genomics 2012 Oct 30;13(1):570. (PMCID: PMC3532379).
  • Bradbury, A.R., Patrick-Miller, L., Egleston, B.L., Schwartz, L.A., Sands, C.B., Shorter, R., Moore, C.W., Tuchman, L., Rauch, P., Malhotra, S., Rowan, B., Van Decker, S., Schmidheiser, H., Bealin, L., Sicilia, P., Daly, M.B.  “Knowledge and Perceptions of Familial and Genetic Risks for Breast Cancer Risk in Adolescent Girls,” Breast Cancer Res Treat 136(3):749-757, 2012. (PMCID: PMC3513641).
  • Livaudais, J.C., Li, C., John, E.M., Terry, M.B., Daly, M., Buys, S.S., Habel, L., Thompson, B., Yanez, N.D., Coronado, G.D. “Racial and Ethnic Differences in Adjuvant Hormonal Therapy Use,” J. Womens Health (Larchmt) 21(9):950-958, 2012. (PMCID: PMC3430474).
  • Cherry, C, Ropka, M., Lyle, J., Napolitano, L., Daly, M.B. “Understanding the Needs of Women Considering Risk Reducing Salpingo-Oophorectomy,” Cancer Nursing 36(3):E33-8, 2013. (PMCID: PMC3637391).
Top

2012

  • Brewster, B.L., Rossiello, F., French, J.D., Edwards, S.L., Wong, M., Wronski, A., Whiley, P., Waddell, N., Chen, X., Bove, B., kConFab, Hopper, J.L., John, E.M., Andrulis, I., Daly, M., Volorio, S., Bernard, L., Peissel, B., Manoukian, S., Barile, M., Pizzamiglio, S., Verderio, P., Spurdle, A.B., Radice, P., Godwin, A.K., Southey, M.C., Brown, M.A., Peterlongo, P.  “Identification of Fifteen Novel Germline Variants in the BRCA1 3’UTR Reveals a Variant in a Breast Cancer Case that Induces a Functional miRNA-103 Target Site,” Human Mutation. 33(12):1665-1675, 2012.
  • Livaudais, J.C., Li, C., John, E.M., Terry, M.B., Daly, M., Buys, S.S., Habel, L., Thompson, B., Yanez, N.D., Coronado, G.D.  “Patterns of Adjuvant Hormonal Therapy Use in the Northern California Breast Cancer Family Registry,” J Womens Health (Larchmt). 21(9):950-958, 2012. (PMCID: PMC3430474).
  • Ding, Y.C., McGuffog, L., Healey, S., Friedman, E., Laitman, Y., Shimon-Paluch, S., Kaufman, B., Liljegren, A., Lindblom, A., Olsson, H., Kristoffersson, U, Stenmark Askmalm, M., Melin, B., Domchek, S.M., Nathanson, K.L., Rebbeck, T.R., Jakubowska, A., Lubinski, J., Jaworska, K., Durda, K., Gronwald, J., Huzarski, T., Cybulski, C., Byrski, T., Osorio, A., Ramony Cajal, T., Stavropoulou, A.V., Benitez, J., Hamann, U., Rookus, M.A., Aalfs, C.M., de Lange, J., Meijers-Heijboer, H.E., Oosterwijk, J.C., van Asperen, C.J., Gomez-Garcia, E.B., Hoogerbrugge, N., Jager, A., van der Luijt, R.B., Easton, D.F., Peock, S., Frost, D., Ellis, S.D., Platte, R., Fineberg, E., Evans, D.G., Lalloo, F., Izatt, L., Eeles, R.A., Adlard, J., Davidson, R., Eccles, D.M., Cole, T., Cook, J., Brewer, C., Tischkowitz, M., Godwin, A.K., Pathak, H.B., Stoppa-Lyonnet, D., Sinilnikova, O.M., Mazoyer, S., Barjhoux, L., Leone, M., Gauthier-Villars, M., Caux-Moncoutier, V., de Pauw, A., Hardouin, A., Berthet, P., Dreyfus, H., Fert Ferrer, S., Collonge-Rame, M.A., Sokolowska, J., Buys, S.S., Daly, M.B., Miron, A., Terry, M.B., Chung, W.K., John, E.M., Southey, M.C., Goldgar, D.E., Singer, C.F., Tea Maria, M.K., Gschwantler-Kaulich, D., Fink-Retter, A., Hansen, T.V., Ejlertsen, B., Johannsson, O.T., Offit, K., Sarrel, K., Gaudet, M.M., Vijai, J., Robson, M.E., Piedmonte, M., Andrews, L., Cohn, D.E., Demars, L.R., Disilvestro, P., Rodriguez, G.C., Toland, A.E., Montagna, M., Agata, S., Imyanitov, E.N., Isaacs, C., Janavicius, R., Lazaro, C., Blanco, I., Ramus, S.J., Sucheston, L.E., Karlan, B.Y., Gross, J., Ganz, P.A., Beattie, M.S., Schmutzler, R.K., Wappenschmidt, B., Meindl, A., Arnold, N., Niederacher, D., Preisler-Adams, S., Gadzicki, D., Varon-Mateeva, R., Deissler, H., Gehrig, A., Sutter, C., Kast, K., Nevanlinna, H., Aittomaki, K., Simard, J., Spurdle, A.B., Beesley, J., Chen, X., Tomlinson, G.E., Weitzel, J.N., Garber, J.E., Olopade, F.I., Rubinstein, W.S., Tung, N., Blum, J.L., Narod, S.A., Brummel, S., Gillen, D.L., Lindor, N.M., Fredericksen, Z., Pankratz, V.S., Couch, F.J., Radice, P., Peterlongo, P., Greene, M.H., Loud, J.T., Mai, P.L., Andrulis, I.L., Glendon, G., Ozcelik, H., Gerdes, A.M., Thomassen, M., Jensen, U.B., Skytte, A.B., Caligo, M.A., Lee, A., Chenevix-Trench, G., Antoniou, A.C., Neuhausen, S.L.  “A Non-synonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 mutation carriers,” Cancer Epidemiol Biomarkers Prev 21(8):1362-1370, 2012. (PMCID: PMC3415567).
  • Couch, F.J., Gaudet, M.M., Antoniou, A.C., Ramus, S.J., Kuchenbaecker, K.B., Soucy, P., Beesley, J., Chen, X., Wang, X., Kirchhoff, T., McGuffog, L., Barrowdale, D., Lee, A., Healey, S., Sinilnikova, O.M., Andrulis, I.L. for OCGN; Ozcelik, H., Mulligan, A., Thomassen, M., Gerdes, A., Jensen, U.B., Skytte, A., Kruse, T.A., Caligo, M.A., von Wachenfeldt, A., Barbany-Bustinza, G., Loman, N., Soller, M., Ehrencrona, H., Karlsson, P. for SWE-BRCA; Nathanson, K.L., Rebbeck, T.R., Domchek, S.M., Jakubowska, A., Lubinski, J., Jaworska, K., Durda, K., Zlowocka, E., Huzarski, T., Byrski, T., Gronwald, J., Cybulski, C., Gorski, B., Osorio, A., Duran, M., Tejada, M.I., Benitez, J., Hamann, U., Hogervorst, F.B.L. for HEBON; van Os, T.A., van Leeuwen, F.E., Meijers-Heijboer, H.E.J., Wijnen, J., Blok, M.J., Kets, M., Hooning, M.J., Oldenburg, R.A., Ausems, M.G.E.M., Peock, S., Frost, D., Ellis, S.D., Platte, R., Fineberg, E., Evans, D.G., Jacobs, C., Eeles, R.A., Adlard, J., Davidson, R., Eccles, D.M., Cole, T., Cook, J., Paterson, J., Brewer, C., Douglas, F., Hodgson, S.V., Morrison, P.J., Walker, L., Porteous, M.E., Kennedy, M.J., Side, L.E. for EMBRACE; Bove, B., Godwin, A.K., Stoppa-Lyonnet, D., GEMO Study Collaborators, Fassy-Colcombet, M., Castera, L., Cornelis, F., Mazoyer, S., Leone, M., Boutry-Kryza, N., Bressac-de Paillerets, B., Caron, O., Pujol, P., Coupier, I., Delnatte, C., Akloul, L., Lynch, H.T., Snyder, C.L., Buys, S.S., Daly, M.B., Terry, M, Chung, W.K., John, E.M., Miron, A., Southey, M.C., Hopper, J.L., Goldgar, D.E., Singer, C.F., Rappaport, C., Tea, M.M., Fink-Retter, A., Hansen, T.V.O., Nielsen, F.C., Arason, A., Vijai, J., Shah, S., Sarrel, K., Robson, M.E., Piedmonte, M., Phillips, K., Basil, J., Rubinstein, W.S., Boggess, J., Wakeley, K., Ewart-Toland, A., Montagna, M., Agata, S., Imyanitov, E.N., Isaacs, C., Janivicius, R., Lazaro, C., Blanco, I., Feliubadalo, L., Brunet, J., Gayther, S.A., Pharoah, P.P.D., Odunsi, K.O., Karlan, B.Y., Walsh, C.S., Olah, E., Teo, S.H., Ganz, P.A., Beattie, M.S., van Rensburg, E.J., Dorfling, C.M., Diez, O., Kwong, A., Schmutzler, R.K., Wappenschmidt, B., Engel, C., Meindl, A., Ditsch, N., Arnold, N., Heidemann, S., Niederacher, D., Preisler-Adams, S., Gadzicki, D., Varon-Mateeva, R., Deissler, H., Gehrig, A., Sutter, C., Kast, K., Fiebig, B., Heinritz, W., Caldes, T., de la Hoya, M., Muranen, T.A., Nevanlinna, H., Tischkowitz, M.D., Spurdle, A.B., Neuhausen, S.L., Ding, Y.C., Lindor, N.M., Fredericksen, Z., Pankratz, V.S., Peterlong, P., Manoukian, S., Peissel, B., Zaffaroni, D., Barile, M., Bernard, L., Viel, A., Giannini, G., Varesco, L., Radice, P., Greene, M.H., Mai, P.L., Easton, D.F., Chenevix-Trench, G. for kConFab investigators; Offit, K., and Simard, J. on behalf of the Consortium of Investigators of Modifiers of BRCA1/2.  “Common Variants at the 19p13.1 and ZNF365 Loci are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers,”Cancer Epidemiology Biomarkers and Prevention, 21(4):645-657, 2012. (PMCID: PMC3319317).
  • Park, D.J., Lesueur, F., Nguyen-Dumont, T., Pertesi, M., Odefrey, F., Hammet, F., Neuhausen, S.L., John, E.M., Andrulis, I.L., Terry, M.B., Daly, M., Buys, S., Le Calvez-Kelm, F., Lonie, A., Pope, B.J., Tsimiklis, H., Voegele, C., Hilbers, F.M., Hoogerbrugge, N., Barroso, A., Osorio, A., the Breast Cancer Family Registry, the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Giles, G.G., Devilee, P., Benitez, J., Hopper, J.L., Tavtigian, S.V., Goldgar, D.E., Southey, M.C. “Rare Mutations in XRCC2 Increase the Risk of Breast Cancer,” American Journal of Human Genetics, 90(4):734-739, 2012. (PMCID: PMC3322233)
  • Ramus, S.J., Antoniou, A.C., Kuchenbaecker, K.B., Soucy, P., Beesley, J., Chen, X., McGuffog, L., Sinilnikova, O.M., Healey, S., Barrowdale, D., Lee, A., Thomassen, M., Gerdes, A.M., Kruse, T.A., Jensen, U.B., Skytte, A.B., Caligo, M.A., Liljegren, A., Lindblom, A., Olsson, H., Kristoffersson, U., Stenmark-Askmalm, M., Melin, B.; SWE-BRCA, Domchek, S.M., Nathanson, K.L., Rebbeck, T.R., Jakubowska, A., Lubinski, J., Jaworska, K., Durda, K., Zlowocka, E., Gronwald, J., Huzarski, T., Byrski, T., Cybulski, C., Toloczko-Grabarek, A., Osorio, A., Benitez, J., Duran, M. Tejada, M.I., Hamann, U., Rookus, M., van Leeuwen, F.E., Aalfs, C.M., Meijers-Heijboer, H.E., van Asperen, C.J., van Roozendaal, K.E., Hoogerbrugge, N., Collee, J.M., Kriege, M., van der Luijt, R.B.; HEBON; EMBRACE, Peock, S., Frost, D., Ellis, S.D., Platte, R., Fineberg, E., Evans, D.G., Lalloo, F., Jacobs, C., Eeles, R., Adlard, J., Davidson, R., Eccles, D., Cole, T., Cook, J., Paterson, J., Douglas, F., Brewer, C., Hodgson, S., Morrison, P.J., Walker, L., Porteous, M.E., Kennedy, M.J., Pathak, H., Godwin, A.K., Stoppa-Lyonnet, D., Caux-Moncoutier, V., de Pauw, A., Gauthier-Villars, M., Mazoyer, S., Leone, M., Calender, A., Lasset, C., Bonadona, V., Hardouin, A., Berthet, P., Bignon, Y.J., Uhrhammer, N., Faivre, L., Loustalot, C.; GEMO, Buys, S., Daly, M., Miron, A., Terry, M.B., Chung, W.K., John, E.M., Southey, M., Goldgar, D., Singer, C.F., Tea, M.K., Pfeiler, G., Fink-Retter, A., Hansen, Tv., Ejlertsen, B., Johannsson, O.T., Offit, K., Kirchhoff, T., Gaudet, M.M., Vijai, J., Robson, M., Piedmonte, M., Phillips, K.A., Van Le, L., Hoffman, J.S., Ewart Toland, A., Montagna, M., Tognazzo, S., Imyanitov, E., Issacs, C., Janavicius, R., Lazaro, C., Blanco, I., Tornero, E., Navarro, M., Moysich, K.B., Karlan, B.Y., Gross, J., Olah, E., Vaszko, T., Teo, S.H., Ganz, P.A., Beattie, M.S., Dorfling, C.M., van Rensburg, E.J., Diez, O., Kwong, A., Schmutzler, R.K., Wappenschmidt, B., Engel, C., Meindl., A., Ditsch, N., Arnold, N., Heidemann, S., Niederacher, D., Preisler-Adams, S., Gadzicki, D., Varon-Mateeva, R., Deissler, H., Gehrig, A., Sutter, C., Kast, K., Fiebig, B., Schafer, D., Caldes, T., de la Hoya, M., Nevanlinna, H., Aittomaki, K., Plante, M., Spurdle, A.B.; kConFab, Neuhausen, S.L., Ding, Y.C., Wang, X., Lindor, N., Fredericksen, Z., Pankratz, V.S., Peterlongo, P., Manoukian, S., Peissel, B., Zaffaroni, D., Bonanni, B., Bernard, L., Dolcetti, R., Papi, L., Ottini, L., Radice, P. Greene, M.H., Mai, P.L., Andrulis, I.L., Glendon, G., Ozcelik, H.; OCGN, Pharoah, P.D., Gayther, S.A., Simard, J., Easton, D.F., Couch, F.J., Chenevix-Trench, G; Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).  “Ovarian Cancer Susceptibility Alleles and Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers,” Hum Mutation, 33(4):690-702, 2012. (PMCID: PMC3458423).
  • Finkelman, B.S., Rubinstein, W.S., Friedman, S., Friebel, T.M., Dubitsky, S., Schonberger, N.S., Shoretz, R., Singer, C.F., Blum, J.L., Tung, N., Olopade, O.I., Weitzel, J.N., Lynch, H.T., Snyder, C., Garber, J.E., Schildkraut, J., Daly, M.B., Isaacs, C., Pichert, G., Neuhausen, S.L., Couch, F.J., van’t Veer, L., Eeles, R., Bancroft, E., Evans, D.G., Ganz, P.A., Tomlinson, G.E., Narod, S.A., Matloff, E., Domchek, S., Rebbeck, T.R. “Breast and Ovarian Cancer Risk and Risk Reduction in Jewish BRCA1/2 Mutation Carriers,” Journal of Clinical Oncology, 30(12):1321-1328, 2012.  (PMCID: PMC3341145)
  • Antoniou, A.C., Kuchenbaecker, K.B., Soucy, P., Beesley, J., Chen, X., McGuffog, L., Lee, A., Barrowdale, D., Healey, S., Sinilnikova, O.M., Caligo, M.A., Loman, N., Harbst, K., Lindblom, A., Arver, B., Rosenquist, R., Karlsson, P., Nathanson, K., Domchek, S., Rebbeck, T., Jaubowska, A., Lubinski, J., Jaworska, K., Durda, K., Zlowocka-Perlowska, E., Osorio, A., Duran, M., Andres, R., Benitez, J., Hamann, U., Hogervorst, F.., A van, O.T., Verhoef, S., Meijers-Heijboer, H.E., Wijnen, J., Gomez Garcia, E.B., Ligtenberg, M.J., Kriege, M., Collee, J.M., Ausems, M.G., Oosterwikj, J.C., Peock, S., Frost, D., Ellis, S.D., Platte, R., Fineberg, E., Evans, D.G., Lalloo, F., Jacobs, C., Eeles, R., Adlard, J., Davidson, R., Cole, T., Cook, J., Paterson, J., Douglas, F., Brewer, C., Hodgson, S., Morrison, P.J., Walker, L., Rogers, M.T., Donaldson, A., Dorkins, H., Godwin, A.K., Bove, B., Stoppa-Lyonnet, D., Houdayer, C., Buecher, B., de Pauw, A., Mazoyer, S., Calendar, A., Leone, M., Bressac-de Paillerets, B., Caron, O., Sobol, H., Frenay,M., Prieur, F., Fert Ferrer, S., Mortemousque, I., Buys, S., Daly, M., Miron, A., Terry, M.B., Hopper, J.L., John, E.M., Southey, M. Goldgar, D., Singer, C.F., Fink-Retter, A., Tea, M.K., Geschwantler Kaulich, D., Hansen, T.V., Nielsen, F.C., Barkardottir, R.B., Gaudet, M., Kirchhoff, T., Joseph, V., Dutra-Clarke, A., Offit, K., Piedmonte, M., Kirk, J., Cohn, D., Hurteau, J., Byron, J., Fiorica, J., Toland, A.E., Montagna, M., Oliani, C., Imyanitov, E., Isaacs, C., Tihomirova, L., Blanco, I., Lazaro, C., Teule, A., Del Valle, J., Gayther, S.A., Odunsi, K., Gross, J., Karlan, B.Y., Olah, E., Teo, S.H., Ganz, P.A., Beattie, M.S., Dorfling, C.M., Jansen van Rensburg, E., Diez, O., Kwong, A., Schmutzler, R.K., Wappenschmidt, B., Engel, C., Meindl, A., Ditsch, N., Arnold, N., Heidemann, S., Niederacher, D., Preisler-Adams, S., Gadzicki, D., Varon-Mateeva, R., Deissler, H., Gehrig, A., Sutter, C., Kast, K., Fiebig, B., Schafer, D., Caldes, T., de la Hoya, M., Nevanlinna, H., Muranen, T.A., Lesperance, B., Spurdle, A.B., Neuhausen, S.L., Ding, Y.C., Wang, X., Fredericksen, Z., Pankratz, V.S., Lindor, N.M., Peterlongo, P., Manoukian, S., Peissel, B., Zaffaroni, D., Bonanni, B., Bernard, L., Dolcetti, R., Papi, L., Ottini, L., Radice, P., Greene, M.H., Loud, J.T., Andrulis, I.L., Ozcelik, H., Mulligan, A.M., Glendon, G., Thomassen, M., Gerdes, A.M., Jensen, U.B., Skytte, A.B., Kruse, T.A., Chenevix-Trench, G., Couch, F.J., Simard, J., Easton, D.F., Swedish Breast Cancer Study SB, Research Facility H, Study E, Study Collaborators G, Investigators K.  “Common Variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are Associated with Breast Cancer Risk for BRCA1 and/or BRCA2 Mutation Carriers,” Breast Cancer Research 14(1):R33, 2012. (PMCID: PMC3496151).
  • Bolton, K.L., Chenevix-Trench, G., Goh, C., Sadetzki, S., Ramus, S.J., Karlan, B.Y., Lambrechts, D., Despierre, E., Barrowdale, D., McGuffog, L., Healey, S., Easton, D.F., Sinilnikova, O., Benitez, J., Garcia, M.J., Neuhausen, S., Gail, M.H., Hartge, P., Peock, S., Frost, D., Evans, G., Eeles, R., Godwin, A.K., Daly, M.B., Kwong, A., Ma, E.S.K., Lazaro, C., Blanco, I., Montagna, M., D’Andrea, E., Nicoletto, M.O., Johnatty, S.E., Kjaer, S.K., Jensen, A., Hogdall, E., Goode, E.L., Fridley, B.L., Loud, J.T., Greene, M.H., Mai, P.L., Chetrit, A., Lubin, F., Hirsh-Yechezkel, G., Glendon, G., Andrulis, I.L., Toland, A.E., Senter, L., Gore, M.E., Gourley, C., Michie, C.O., Song, H., Tyrer, J., Whittemore, A.S., McGuire, V., Sieh, W., Kristoffersson, U., Olsson, H., Borg, A., Levine, D.A., Steele, L., Beattie, M.S., Chan, S., Nussbaum, R.L., Moysich, K.B., Gross, J., Cass, I., Walsh, C., Li, A.J., Leuchter, R., Gordon, O., Garcia-Closas, M., Gayther, S.A., Chanock, S.J., Antoniou, A.C., Pharoah, P.D.P. for the EMBRACE, kConFab Investigators and The Cancer Genome Atlas Research Network. “Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer,” JAMA 307(4):382-390, 2012.
  • Bradbury, A.R., Patrick-Miller, L., Egleston, B.L., Olopade, O.I., Daly, M.B., Moore, C.W., Sands, C.B., Schmidheiser, H., Kondamudi, P.K., Feigon, M., Ibe, C.N., Daugherty, C.K. “When Parents Disclose BRCA1/2 Test Results: Their Communication and Perceptions of Offspring Response,” Cancer, 118(13):3417-3425, 2012. (PMCID: PMC3326182).
Top

2011

  • Im, K.M., Kirchhoff, T., Wang, X., Green, T., Chow, C.Y., Vijai, J., Korn, J., Gaudet, M.M., Fredericksen, Z., Shane Pankratz, V., Guiducci, C., Crenshaw, A., McGuffog, L., Kartsonaki, C., Morrison, J., Healey, S., Sinilnikova, O.M., Mai, P.L., Greene, M.H., Piedmonte, M., Rubinstein, W.S.; HEBON, Hogervorst, F.B., Rookus, M.A., Collee, J.M., Hoogerbrugge, N., van Asperen, C.J., Meijers-Heijboer, H.E., Van Roozendaal, C.E., Caldes, T., Perez-Segura, P., Jakubowska, A., Lubinski, J., Huzarski, T., Blecharz, P., Nevanlinna, H., Aittomaki, K., Lazaro, C., Blanco, I., Barkardottir, R.B., Montagna, M., D’Andrea, E; kConFab, Devilee, P., Olopade, O.I., Neuhausen, S.L., Peissel, B., Bonanni, B., Peterlongo, P., Singer, C.F., Rennert, G., Lejbkowicz, F., Andrulis, I.L., Glendon, G., Ozcelik, H; Ontario Cancer Genetics Network, Toland, A.E., Caligo, M.A.; SWE-BRCA, Beattie, M.S., Chan, S; UKFOCR, Domchek, S.M., Nathanson, K.L., Rebbeck, T.R., Phelan, C., Narod, S., John, E.M., Hopper, J.L., Buys, S.S., Daly, M.B., Southey, M.C., Terry, M.B., Tung, N., Hansen, T.V., Osorio, A., Benitez, J., Duran, M., Weitzel, J.N., Garber, J., Hamann U; EMBRACE, Peock, S., Cook, M., Oliver, C.T., Frost, D., Platte, R., Evans, D.G., Eeles, R., Izatt, L., Paterson, J., Brewer, C., Hodgson, S., Morrison, P.J., Porteous, M., Walker, L., Rogers, M.T., Side, L.E., Godwin, A.K., Schmutzler, R.K., Wappenschmidt, B., Laitman, Y., Meindl, A., Deissler, H., Varon-Mateeva, R., Preisler-Adams, S., Kast, K., Venat-Bouvet, L., Stoppa-Lyonnet, D., Chenevix-Trench, G., Easton, D.F., Klein, R.J., Daly, M.J., Friedman, E., Dean, M., Clark, A.G., Altshuler, D.M., Antoniou, A.C., Couch, F.J., Offit, K., Gold, B.  “Haplotype Structure in Ashkenazi Jewish BRCA1 and BRCA2 Mutation Carriers,” Human Genetics, 130(5):685-699, 2011. (PMCID: PMC3196382).
  • Adams, S.F., Marsh, E.B., Elmasri, W., Halberstadt, S., Vandecker, S., Sammel, M.D., Bradbury, A.R., Daly, M., Karlan, B., Rubin, S.C., “A High Response Rate to Liposomal Doxorubicin is Seen Among Women with BRCA Mutations Treated for Recurrent Epithelial Ovarian Cancer,” Gynecol Oncol 123(3):486-491, 2011. (PMCID: PMC3260049).
  • Maxwell, C.A., Benitez, J., Gomez-Baldo, L., Osorio, A., Bonifaci, N., Fernandez-Ramires, R., Costes, S.V., Guino, E., Chen, H., Evans, G.J., Mohan, P., Catala, I., Petit, A., Aguilar, H., Villanueva, A., Aytes, A., Serra-Musach, J., Rennert, G., Lejbkowicz, F., Peterlongo, P., Manoukian, S., Peissel, B., Ripamonti, C.B., Bonanni, B., Viel, A., Allavena, A., Bernard, L., Radice, P., Friedman, E., Kaufman, E., Kaufman, B., Laitman, Y., Dubrovsky, M., Milgrom, R., Jakubowska, A., Cybulski, C., Gorski, B., Jaworska, K., Durda, K., Sukiennicki, G., Lubinski, J., Shugart, Y.Y., Domchek, S.M., Letrero, R., Weber, B.L., Hogervorst, F.B., Rookus, M.A., Collee, J.M., Devilee, P., Ligtenberg, M.J., van der Luijt, R.B., Aalfs, C.M., Waisfisz, Q., Wijnen, J., van Roozendaal, C.E.; HEBON; EMBRACE, Easton, D.F., Peock, S., Cook, M., Oliver, C., Frost, D., Harrington, P., Evans, D.G., Lalloo, F., Eeles, R., Izatt, L., Chu, C., Eccles, D., Douglas, F., Brewer, C., Nevanlinna, H., Heikkinen, T., Couch, F.J., Lindor, N.M., Wang, X., Godwin, A.K., Caligo, M.A., Lombardi, G., Loman, N., Karlsson, P., Ehrencrona, H., von Wachenfeldt, A; SWE-BRCA, Bjork Barkardottir, R., Hamann, U., Rashid, M.U., Lasa, A., Caldes, T., Andres, R., Schmitt, M., Assmann, V., Stevens, K., Offit, K., Curado, J., Tilgner, H., Guigo, R., Aiza, G., Brunet, J., Castellsague, J., Martrat, G., Urruticoechea, A., Blanco, I., Tihomirova, L., Goldgar, D.E., Buys, S., John, E.M., Miron, A., Southey, M., Daly, M.B.; BCFR, Schmutzler, R.K., Wappenschmidt, B., Meindl, A., Arnold, N., Deissler, H., Varon-Mateeva, R., Sutter, C., Niederacher, D., Imyamitov, E., Sinilnikova, O.M., Stoppa-Lyonne, D., Mazoyer, S., Verny-Pierre, C., Castera, L., de Pauw, A., Bignon, Y.J., Uhrhammer, N., Peyrat, J.P., Vennin, P., Fert Ferrer, S., Collonge-Rame, M.A., Mortemousque, I; GEMO Study Collaborators, Spurdle, A.B., Beesley, J., Chen, X., Healey, S; kConFab, Barcellos-Hoff, M.H., Vidal, M., Gruber, S.B., Lazaro, C., Capella, G., McGuffog, L., Nathanson, K.L., Antoniou, A.C., Chenevix-Trench, G., Fleisch, M.C., Moreno, V., Pujana, M.A.  “Interplay Between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer,” PLoS Biol, 9(11):e1001199, 2011. (PMCID: PMC3217025).
  • Antoniou, A.C., Kartsonaki, C., Sinilnikova, O.M., Soucy, P., McGuffog, L., Healey, S., Lee, A., Peterlongo, P., Manoukian, S., Peissel, B., Zaffaroni, D., Cattaneo, E., Barile, M., Pensotti, V., Pasini, B., Dolcetti, R., Giannini, G., Putignano, A.L., Varesco, L., Radice, P., Mai, P.L., Greene, M.H., Andrulis, I.L., Glendon, G., Ozcelik, H., Thomassen, M., Gerdes, A.M., Kruse, T.A., Birk Jensen, U., Cruger, D.G., Caligo, M.A., Laitman, Y., Milgrom, R., Kaufman, B., Paluch-Shimon, S., Friedman, E., Loman, N., Harbst, K., Lindblom, A., Arver, B., Ehrencrona, H., Melin, B; SWE-BRCA, Nathanson, K.L., Domchek, S.M., Rebbeck, T., Jakubowska, A., Lubinski, J., Gronwald, J., Huzarski, T., Byrski, T., Cybulski, C., Gorski, B., Osorio, A., Ramon y Cajal, T., Fostira, F., Andres, R., Benitez, J., Hamann, U., Hogervorst, F.B., Rookus, M.A., Hooning, M.J., Nelen, M.R., van der Luijt, R.B., van Os, T.A., van Asperen, C.J., Devilee, P., Meijers-Heijboer, H.E., Garcia, E.B; HEBON, Peock, S., Cook, M., Frost, D., Platte, R., Leyland, J., Evans, D.G., Lalloo, F., Eeles, R., Izatt, L., Adlard, J., Davidson, R., Eccles, D., Ong, K.R., Cook, J., Douglas, F., Paterson, J., Kennedy, M.J., Miedzybrodzka, Z; EMBRACE, Godwin, A., Stoppa-Lyonnet, D., Buecher, B., Belotti, M., Tirapo, C., Mazoyer, S., Barjhoux, J., Lasset, C., Leroux, D., Faivre, L., Bronner, M., Prieur, F., Nogues, C., Rouleau, E., Pujol, P., Coupier, I., Frenay, M; CEMO Study Collaborators, Hopper, J.L., Daly, M.B., Terry, M.B., John, E.M., Buys, S.S., Yassin, Y., Miron, A., Goldgar, D; Breast Cancer Family Registry, Singer, C.F., Tea, M.K., Pfeiler, G., Dressler, A.C., Hansen, T.O., Jonson, L., Ejlertsen, B., Barkardottir, R.B., Kirchhoff, T., Offit, K., Piedmonte, M., Rodriguez, G., Small, L., Boggess, J., Blank, S., Basil, J., Azodi, M., Toland, A.E., Montagna, M., Tognazzo, S., Agata, S., Imyanitov, E., Janavicius, R., Lazaro, C., Blanco, I., Pharoah, P.D., Sucheston, L., Karlan, B.Y., Walsh, C.S., Olah, E., Bozsik, A., Teo, S.H., Seldon, J.L., Beattie, M.S., van Rensburg, E.J., Sluiter, M.D., Diez, O., Schmutzler, R.K., Wappenschmidt, B., Engel, C., Meindl, A., Ruehl, I., Varon-Mateeva, R., Kast, K., Deissler, H., Niederacher, D., Arnold, N., Gadzicki, D., Schonbuchner, I., Caldes, T., de la Hoya, M., Nevanlinna, H., Aittomaki, K., Dumont, M., Chiquette, J., Tischkowitz, M., Chen, X., Beesley, J., Spurdle, A.B., kConFab investigators, Neuhausen, S.L., Chun Ding, Y., Fredericksen, Z., Wang, X., Pankratz, V.S., Couch, F., Simard, J., Easton, D.F., Chenevix-Trench, G; CIMBA.  “Common Alleles at 6q25.1 and 1p11.2 are Associated with Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers,” Human Molecular Genetics, 20(16):3304-3321, 2011. (PMCID: PMC3319317).
  • Mulligan, A.M., Couch, F.J., Barrowdale, D., Domchek, S.M., Eccles, D., Nevanlinna, H., Ramus, S.J., Robson, M., Sherman, M., Spurdle, A.B., Wappenschmidt, B., Lee, A., McGuffog, L., Healey, S., Sinilnikova, O.M., Janavicius, R., Hansen, T.V., Nielsen, F.C., Ejlertsen, B., Osorio, A., Munoz-Repeto, I., Duran, M., Godino, J., Pertesi, M., Benitez, J., Peterlongo, P., Manoukian, S., Peissel, B., Zaffaroni, D., Cattaneo, E., Bonanni, B., Viel, A., Pasini, B., Papi, L., Ottini, L., Savarese, A., Bernard, L., Radice, P., Hamann, U., Verheus, M., Meijers-Heijboer, H.E., Wijnen, J., Gomez Garcia, E.B., Nelen, M.R., Kets, C.M., Seynaeve, C., Tilanus-Linthorst, M.M., van der Luijt, R.B., van Os, T., Rookus, M., Frost, D., Jones, J.L., Evans, D.G., Lalloo, F., Eeles, R., Izatt, L., Adlard, J., Davidson, R., Cook, J., Donaldson, A., Dorkins, H., Gregory, H., Eason, J., Houghton, C., Barwell, J., Side, L.E., McCann, E., Murray, A., Peock, S., Godwin, A., Schmutzler, R.K., Rhiem, K., Engel, C., Meindl, A.Ruehl, I., Arnold, N., Niederacher, D., Sutter, C., Deissler, H., Gadzicki, D., Kast, K., Preisler-Adams, S., Varon-Mateeva, R., Schoenbuchner, I., Fiebig, B., Heinritz, W., Schafer, D., Gevensleben, H., Caux-Moncoutier, V., Fassy-Colcombet, M., Cornelis, F., Mazoyer, S., Leone, M., Boutry-Kryza, N., Hardouin, A., Berthet, P., Muller, D., Fricher, J.P., Mortemousque, I., Pujol, P., Coupier, I., Lebrun, M., Kientz, C., Longy, M., Sevenet, N., Stoppa-Lyonnet, D., Isaacs, C., Caldes, T., de Al Hoya, M., Heikkinen, T., Aittomaki, K., Blanco, I., Lazaro, C., Barkardottir, R.B., Soucy, P., Dumont, M., Simard, J., Montagna, M., Tognazzo, S., D’Andrea, E., Fox, S., Yan, M., Rebbeck, T.R., Olopade, O.I., Weitzel, J.N., Lynch, H.T., Ganz, P.A., Tomlinson, G.E., Wang, X., Fredericksen, Z., Pankratz, V.S., Lindor, N.M., Szabo, C., Offit, K., Sakr, R., Gaudet, M., Bhatia, J., Kauff, N., Singer, C.F., Tea, M.K., Gschwantler-Kaulich, D., Fink-Retter, A., Mai, P.L., Greene, M.H., Imyanitov, E., O’Malley, F.P., Ozcelik, H., Glendon, G., Toland, A.E., Gerdes, A.M., Thomassen, M., Kruse, T.A., Birk Jensen, U., Skytte, A.B., Caligo, M.A., Soller, M., Henriksson, K., von Wachenfeldt, A., Arver, B., Stenmark-Askmalm, M., Karlsson, P., Ding, Y.C., Neuhausen, S.L., Beattie, M., Pharoah, P.D., Moysich, K.B., Nathanson, K.L., Karlan, B.Y., Gross, J., John, E.M., Daly, M.B., Buys, S.M., Southey, M.C., Hopper, J.L., Terry, M.B., Chung, W., Miron, A.F., Goldgar, D., Chenevix-Trench, G., Easton, D.F., Andrulis, I.L., Antoniou, A.C., Family Registry BC, Embrace, Collaborators GS, Hebon, Network O, Swe-Brca, Cimba.  “Common Breast Cancer Susceptibility Alleles are Associated with Tumor Subtypes in BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2,” Breast Cancer Research, 13(6):R110. (PMCID: PMC3326552).
  • Rebbeck, T.R., Mitra, N., Domchek, S.M., Wan, F., Friebel, T.M., Tran, T.V., Singer, C.F., Tea, M.K., Blum, J.L., Tung, N., Olopade, O.I., Weitzel, J.N., Lynch, H.T., Snyder, C.L., Garber, J.E., Antoniou, A.C., Peock, S., Evans, D.G., Paterson, J., Kennedy, M.J., Donaldson, A., Dorkins, H., Easton, D.F.; Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), Rubinstein, W.S., Daly, M.B., Isaacs, C., Nevanlinna, H., Couch, F.J., Andrulis, I.L., Freidman, E., Laitman, Y., Ganz, P.A., Tomlinson, G.E., Neuhausen, S.L., Narod, S.A., Phelan, C.M., Greenberg, R., Nathanson, K.L.  “Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes,” Cancer Research, 71(17):5792-805, 2011. (PMCID: PMC3170727).
  • Skates, S.J., Mai, P., Horick, N.K., Piedmonte, M., Drescher, C.W., Isaacs, C., Armstrong, D.K., Buys, S.S., Rodriguez, G.C., Horowitz, I.R., Berchuck, A., Daly, M.B., Domchek, S., Cohn, D.E., Van Le, L., Schorge, J.O., Newland, W., Davidson, S.A., Barnes, M., Brewster, W., Azodi, M., Nerenstone, S., Kauff, N.D., Fabian, C.J., Sluss, P.M., Nayfield, S.G., Kasten, C.H., Finkelstein, D.M., Greene, M.H., Lu, K.  “Large Prospective Study of Ovarian Cancer Screening in High-Risk Women: CA125 Cut-Point Defined by Menopausal Status,” Cancer Prevention Research 4(9):1401-1408, 2011. (PMCID: PMC3172691)
  • Neuhausen, S.L., Brummel, S., Ding, Y.C., Steele, L., Nathanson, K.L., Comchek, S., Rebbeck, T.R., Singer, C.F., Pfeiler, G., Lynch, H.T., Garber, J.E., Couch, F., Weitzel, J.N., Godwin, A., Narod, S.A., Ganz, P.A., Daly, M.B., Isaacs, C., Olopade, O.I., Tomlinson, G.E., Rubinstein, W.S., Tung, N., Blum, J.L., Gillen, D.L.  “Genetic Variation in IGF2 and HTRA1 and Breast Cancer Risk among BRCA1 and BRCA2 Carriers,” Cancer Epidemiol Biomarkers Prev 20(8):1690-702, 2011. (PMCID: PMC3352680)
  • Goldgar, D.E., Healey, S., Dowty, J.G., Da Silva, L., Chen, X., Spurdle, A.B., Terry, M., Daly, M., Buys, S.M., Southey, M.C., Andrulis, I., John, E.M., Bcfr B, KConFab K, Hopper, J.L., Oefner, P.J., Lakhani, S., Chenevix-Trench, G. “Rare Variants in the ATM Gene and Risk of Breast Cancer,” Breast Cancer Research 13:R73, 2011.  (PMCID: PMC3236337).
  • Roussi, P., Sherman, K.A., Miller, S.M., Hurley, K., Daly, M.B., Godwin, A., Buzaglo, J.S., Wen, K-Y.  “Identification of Cognitive Profiles Among Women Considering BRCA1/2 Testing Through the Utilization of Cluster Analytic Techniques,” Psychology & Health, DOI:10.1080/08870446.2010.521938, 2011. (PMCID: PMC3197930)
  • Martrat, G., Maxwell, C.A., Tominagoa, E., Porta, M., Bonifaci, N., Gomez-Baldo, L., Bogliolo, M., Lazaro, C., Blanco, I., Brunet, J., Aguilar,H., Fernandez-Rodriguez, J., Seal, S., Renwick, A., Rahman, N., Kuhl, J., Neveling, K., Schindler, D., Ramirez, M.J., Castella, M., Hernandez, G., Embrace, E.S., Easton, D.F., Peock, S., Cook, M., Oliver, C.T., Frost, D., Platte, R., Evans, D.G., Lalloo, F., Eeles, R., Izatt, L., Chu, C., Davidson, R., Ong, K.R., Cook, J., Douglas, F., Hodgson, S., Brewer, C., Morrison, P.J., Porteous, M., Peterlongo, P., Manoukian, S., Peissel, B., Zaffaroni, D., Roversi, G., Barile, M., Viel, A., Pasini, B., Ottini, L., Putignano, A.L., Savarese, A., Bernard, L., Radice, P., Healey, S., Spurdle, A., Chen, X., Beesley, J., Kconfab KC, Rookus, M.A., Verhoef, S., Tilanus-Linthorst, M.A., Vreeswijk, M.P., Asperen, C.J., Bodmer, D., Ausems, M.G., van Os, T.A., Blok, M.J., Meijers-Heijboer, H.E., Hogervorst, F.B., Hebon, H.B., Goldgar, D.E., Buys, S., John, E.M., Miron, A., Southey, M., Daly, M.B., Bcfr BC, Swe-Brca SB, Harbst, K., Borg, A., Rantala, J., Barbany-Bustinza, G., Ehrencrona, H., Stenmark-Askmalm, M., Kaufman, B., Laitman, Y., Milgrom, R., Friedman, E., Domchek, S.M., Nathanson, K.L., Rebbeck, T.R., Johannsson, O.T., Couch, F.J., Wang, X., Fredericksen, Z., Cuadras, D., Moreno, V., Pientka, F.K., Depping, R., Caldes, T., Osorio, A., Benitez, J., Bueren, J., Heikkinen, T., Nevanlinna, H., Hamann, U., Torres, D., Caligo, M.A., Godwin, A.K., Imyanitov, E.N., Janavicius, R., Gemo, G.G., Sinilnikova, O.M., Stoppa-Lyonnet, D., Mazoyer, S., Verny-Pierre, C., Castera, L., de Pauw, A., Bignon, Y.J., Uhrhammer, N., Peyrat, J.P., Vennin, P., Fert Ferrer, S., Collonge-Rame, M.A., Mortemousque, I., McGuffog, L., Chenevix-Trench, G., Pereira-Smith, O.M., Antoniou, A.C., Ceron, J., Tominga, K., Surralles, J., Pujana, M.A.  “Exploring the Link Between MORF4L1 and Risk of Breast Cancer,” Breast Cancer Res. 13(2):R40, 2011. (PMCID: PMC3219203)
  • Spurdle, M., Marquart, L., McGuffog, L., Healey, S., Sinilnikova, O.M., Wan, F., Chen, X., Beesley, J., Singer, C.F., Dressler, A.C., Gschwantler-Kaulich, D., Blum, J.L., Tung, N., Weitzel, J.N., Lynch, H.T., Garber, J.E., Easton, D., Peock, S., Cook, M., Oliver, C.T., Frost, D., Conroy, D., Evans, D.G., Lalloo, F., Eeles, R.A., Izatt, L., Davidson, R., Chu, C., Eccles, D., Selkirk, C.G., Daly, M.B., Isaacs, C., Stoppa-Lyonet, D., Buecher, B., Belotti, M., Mazoyer, S., Barjhoux, L., Verny-Pierre, C., Lasset, C., Dreyfus, H., Pujol, P., Collonge-Rame, M.A., Collaborators GS, Rookus, M.A., Verhoef, S., Kriege, M., Hoogerbrugge, N., Ausems, M.G., van Os, T.A., Wijnen, J.T., Devilee, P., Meijers-Heijboer, H.E., Blok, M.J., Heikkinen, T., Nevanlinna, H.A., Jakubowska, A., Lubinski, J., Huzarski, T., Byrski, T., Durocher, F., Couch, F.J., Lindor, N.M., Wang, X., Thomasson, M., Domchek, S.M., Nathanson, K.L., Caligo, M.A., Jernstrom, H.C., Liljegren, A., Ehrencrona, H., Karlsson, P., Ganz, P.A., Olopade, O.I., Tomlinson, G., Neuhausen, S.L., Antoniou, A.C., Chenevix-Trench, G., Rebbeck, T.R. “Common Genetic Variation at BARD1 is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers,” Cancer Epidemiology Biomarkers and Prevention 20(5):1032-1038, 2011. (PMCID: PMC3089675).
  • Schrader, K.A., Masciari, S., Boyd, N., Salamanca, C., Senz, J., Saunders, D.N., Yorida, E., Maines-Bandiera, S., Kaurah, P., Tung, N., Robson, M.E., Ryan, P.D., Olopade, O.I., Domchek, S.M., Ford, J., Isaacs, C., Brown, P., Balmana, J., Razzak, A.R., Miron, P., Coffey, K., Terry, M.B., John, E.M., Andrulis, I.L., Knight, J.A., O’Malley, F.P., Daly, M.B., Bender, P.; kConFab, Moore, R., Southey, M.C., Hopper, J.L., Garber, J.E., Huntsman, D.G.  “Germline Mutations in CDH1 are Infrequent in Women with Early-Onset or Familial Lobular Breast Cancers,” J Med Genet 48(1):64-68, 2011 (PMCID: PMC3003879).
  • Smith, L.D., Tesoriero, A.A., Wong, E.M., Ramus, S.J., O’Malley, F.P., Mulligan, A.M., Terry, M.B., Senie, R.T., Santella, R.M., John, E.M., Andrulis, I.L., Ozcelik, H., Daly, M.B., Godwin, A.K., Buys, S.S., Fox, S., Goldgar, D.E., Giles, G.G., Hopper, J.L., Southey, M.C. “Contribution of Large Genomic BRCA1 Alterations to Early-Onset Breast Cancer Selected for Family History and Tumour Morphology: A Report from The Breast Cancer Family Registry,” Breast Cancer Res 13(1):R14, 2011. (PMCID: PMC3109582)
  • Ramus, S.J., Kartsonaki, C., Gayther, S.A., Pharoah, P.D.P., Sinilnikova, O.M., Beesley, J., Chen, X., McGuffog, L., Healey, S., Couch, F.J., Wang, X., Fredericksen, Z., Peterlongo, P., Manoukian, S., Peissel, B., Zaffaroni, D., Roversi, G., Barile, M., Viel, A., Allavena, A., Ottini, L., Papi, L, Gismondi, V., Capra, F., Radice, P., Greene, M.H., Mai, P.L., Andrulis, I.L., Glendon, G., Ozcelik, H., OCGN, Thomassen, M., Gerdes, A-M., Kruse, T.A., Cruger, D., Jensen, U.B., Caligo, M.A., Olsson, H., Kristoffersson, U., Lindblom, A., Arver, B., Karlsson, P., Askmalm, M.S., Borg, A., Neuhausen, S.L., Ding, Y.C., Nathanson, K.L., Domchek, S.M., Jakubowska, A., Lubinski, J., Huzarski, T., Byrski, T., Gronwald, J., Gorski, B., Cybulsi, C., Debniak, T., Osorio, A., Duran, M., Tejada, M-I., Benitez, J., Hamann, U., Rookus, M.A., Verhoef, S., Tilanus-Linthorst, M.A., Vreeswijk, M.P., Bodmer, D., Ausems, M.G.E.M., van Os, T.A., Asperen, C.J., Blok, M.J., Meijers-Heijboer, H.E.J., HEBON, EMBRACE, Peock, S., Cook, M., Oliver, C., Frost, D., Dunning, A.M., Evans, D.E., Eeles, R., Pichert, G., Cole, T., Hodgson, S., Brewer, C., Morrison, P.J., Porteous, M., Kennedy, M.J., Rogers, M.T., Side, L.E., Donaldson, A., Gregory, H., Godwin, A., Stoppa-Lyonnet, D., Moncoutier, V., Castera, L., Mazoyer, S., Barjhoux, L., Bonadona, V., Leroux, D., Faivre, L., Lidereau, R., Nogues, C., Bignon, Y-J., Prieur, F., Collonge-Rame, M-A., Venat-Bouvet, L., Fert-Ferrer, S., GEMO Study Collaborators, Miron, A., Buys, S.S., Hopper, J.L., Daly, M.B., John, E.M., Terry, M.B., Goldgar, D., BCFR, Hansen, T.v.O., Jonson, L., Ejlertsen, B., Agnarsson, B.A., Offit, K., Kirchhoff, T., Vijai, J., Dutra-Clarke, A.V.C., Przybylo, J.A., Montagna, M., Casella, C., Imyanitov, E.N., Janavicius, R., Blanco, I., Lazaro, C., Moysich, K.B., Karlan, B.Y., Gross, J., Beattie, M.S., Schmutzler, R., Wappenschmidt, B., Meindl, A., Ruehl, I., Fiebig, B., Sutter, C., Arnold, N., Deissler, H., Varon-Mateeva, R., Kast, K., Niederacher, D., Gadzicki, D., Caldes, T., del la Hoya, M., Nevanlinna, H., Aittomaki, K., Simard, J., Soucy, P., kConFab Investigators, Spurdle, A.B., Holland, H., Chenevix-Trench, G., Easton, D.F., Antoniou, A.C. on behalf of Consortium of Investigators of Modifiers of BRCA1/2.  “Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers,” J Natl Cancer Inst 103:1-12, 2011. (PMCID: PMC3107565).
  • Meropol, N.J., Daly, M.B., Vig, H.S., Manion, F.J., Manne, S.L., Mazar, C., Murphy, C., Solarino, N., Zubarev, V.  “Delivery of Internet-based Cancer Genetic Counseling Services to Patients’ Homes: a Feasibility Study,” Journal of Telemedicine and Telecare 17(1):36-40, 2011. (PMCID: PMC3263376).
  • Bradbury, A., Patrick-Miller, L., Fetzer, D., Egleston, B., Cummings, S., Forman, A., Bealin, L., Peterson, C., Corbman, M., O’Connell, J., Daly, M.  “Genetic Counselor Opinions of, and Experiences with Telephone Communication of BRCA1/2 Test Results,” Clinical Genetics 79(2):125-131, 2011 (PMCID: PMC3059740).
Top

2010

  • Gaudet, M.M., Kirchhoff, T., Green, T., Vijai, J., Korn, J.M., Guiducci, C., Segre, A.V., McGee, K., McGuffog, L., Kartsonaki, C., Morrison, J., Healey, S., Sinilnikova, O.M., Stoppa-Lyonnet, D., Mazoyer, S., Gauthier-Villars, M., Sobol, H., Longy, M., Frenay, M., GEMO Study Collaborators, Hogervorst, F.B., Rookus, M.A., Collee, J.M., Hoogerbrugge, N., van Roozendall, K.E.; HEBON Study Collaborators, Piedmonte, M., Rubinstein, W., Nerenstone, S., Van Le, L., Blank, S.V., Caldes, T., de la Hoya, M., Nevanlinna, H., Aittomaki, K., Lazaro, C., Blanco, I., Arason, A., Johannsson, O.T., Barkardottir, R.B., Devilee, P., Olopade, O.I., Neuhausen, S.L., Wang, X., Fredericksen, Z.S., Peterlongo, P., Manoukian, S., Barile, M., Viel, A., Radice, P., Phelan, C.M., Narod, S., Rennert, G., Lejbkowicz, F., Flugelman, A., Andrulis, I.L., Glendon, G., Ozcelik, H.; OCGN, Toland, A.E., Montagna, M., D’Andrea, E., Friedman, E., Laitman, Y., Borg, A., Beattie, M., Ramus, S.J., Domchek, S.M., Nathanson, K.L., Rebbeck, T., Spurdle, A.B., Chen, X., Holland, H.; kConFab, John, E.M., Hopper, J.L., Buys, S.S., Daly, M.B., Southey, M.C., Terry, M.B., Tung, N., Overeem Hansen, T.V., Nielsen, F.C., Greene, M.H., Mai, P.L., Osorio, A., Duran, M., Andres, R., Benitez, J., Weitzel, J.N., Garber, J., Hamann, U.; EMBRACE, Peock, S., Cook, M., Oliver, C., Frost, D., Platte, R., Evans, D.G., Lalloo, F., Eeles, R., Izatt, L., Walker, L., Eason, J., Barwell, J., Godwin, A.K., Schmutzler, R.K., Wappenschmidt, B., Engert, S., Arnold, N., Gadzicki, D., Dean, M., Gold, B., Klein, R.J., Couch, F.J., Chenevix-Trench, G., Easton, D.F., Daly, M.J., Antoniou, A.C., Altshuler, D.M., Offit, K. “Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer,” PLoS Genet 6(10):e10001183, 2010.(PMCID: PMC2965747).
  • Antoniou, A.C., Wang, X., Fredericksen, Z.S., McGuffog, L., Tarrell, R., Sinilnikova, O.M., Healey, S., Morrison, J., Kartsonaki, C., Lesnick, T., Ghoussaini, M., Barrowdale, D., EMBRACE, Peock, S., Cook, M., Oliver, C., Frost, D., Eccles, D., Evans, D.G., Eeles, R., Izatt, L., Chu,C., Douglas, F., Paterson, J., Stoppa-Lyonnet, D., Houdayer, C., Mazoyer, S., Giraud, S., Lasset, C., Remenieras, A., Caron, O., Hardouin, A., Berthet, P.; GEMO Study Collaborators, Hogervorst, F.B., Rookus, M.A., Jager, A., van den Ouweland, A., Hoogerbrugge, N., van der Luijt, R.B., Meijers-Heijboer, H., Gomez Garcia, E.B.; HEBON, Devilee, P., Vreeswijk, M.P., Lubinski, J., Jakubowska, A., Gronwald, J., Huzarski, T., Byrski, T., Gorski, B., Cybulski, C., Spurdle, A.B., Holland, H; kConFab, Goldgar, D.E., John, E.M., Hopper, J.L., Southey, M., Buys, S.S., Daly, M.B., Terry, M.B., Schmutzler, R.K., Wappenschmidt, B., Engel, C., Meindl, A., Preisler-Adams, S., Arnold, N., Niederacher, D., Sutter, C., Domchek, S.M., Nathanson, K.L., Rebbeck, T., Blum, J.L., Piedmonte, M., Rodriguez, G.C., Wakeley, K., Boggess, J.F., Basil, J., Blank, S.V., Friedman, E., Kaufman, B., Laitman, Y., Milgrom, R., Andrulis, I.L., Glendon, G., Ozcelik, H., Kirchhoff, T., Vijai, J., Gaudet, M.M., Altshuler, D., Guiducci, C.; SWE-BRCA, Loman, H., Harbst, K., Rantala, J., Ehrencrona, H., Gerdes, A.M., Thomassen, M., Sunde, L., Peterlongo, P., Manoukian, S., Bonanni, B., Viel, A., Radice, P., Caldes, T., de la Hoya, M., Singer, C.F., Fink-Retter, A., Greene, M.H., Mai, P.L., Loud, J.T., Guidugli, L., Lindor, N.M., Hansen, T.V., Nielsen, F.C. Blanco, I., Lazaro, C., Garber, J., Ramus, S.J., Gayther, S.A., Phelan, C., Narod, S., Szabo, C.I; MOD SQUAD, Benitez, J., Osorio, A., Nevanlinna, H., Heikkinen, T., Caligo, M.A., Beattie, M.S., Hamann, U., Godwin, A.K., Montagna, M., Casella, C., Neuhausen, S.L., Karlan, B.Y., Tung, N.,Toland, A.E., Weitzel, J., Olopade, O., Simard, J., Soucy, P., Rubinstein, W.S., Arason, A., Rennert, G., Martin, N.G., Montgomery, G.W., Chang-Claude, J., Flesch-Janys, D., Brauch, H; GENICA, Severi, G., Baglietto, L., Cox, A., Cross, S.S., Miron, P., Gerty, S.M., Tapper, W., Yannoukakos, D., Fountzilas, G., Fasching, P.A., Beckmann, M.W., Dos Santos Silva, I., Peto, J., Lambrechts, D., Paridaens, R., Rudiger, T., Forsti, A., Winqvist, R., Pylkas, K., Diasio, R.B., Lee, A.M., Eckel-Passow, J., Vachon, C., Blows, F., Driver, K., Dunning, A., Pharoah, P.P., Offit, K., Pankratz, V.S., Hakonarson, H., Chenevix-Trench, G., Easton, D.F., Couch, F.J. “A Locus on 19p13 Modifies Risk of Breast Cancer in BRCA1 Mutation Carriers and is Associated with Hormone Receptor-Negative Breast Cancer in the General Population,” Nat Genet 42(10):885-892, 2010. (PMCID: PMC3130795).
  • Holmberg, C., Daly, M., McCaskill-Stevens, W.  “Risk Scores and Decision Making: the Anatomy of a Decision to Reduce Breast Cancer Risk,” Journal of Nursing and Healthcare of Chronic Illness 2(4):271-280, 2010. (PMCID: PMC3124706)
  • Antoniou, A.C., Beesley, J., McGuffog, L., Sinilnikova, O.M., Healey, S., Neuhausen, S.L., Ding, Y.C., Rebbeck, T.R., Weitzel, J.N., Lynch, H.T., Isaacs, C., Ganz, P.A., Tomlinson, G., Olopade, O.I., Couch, F.J., Wang, X., Lindor, N.M., Pankratz, V.S., Radice, P., Manoukian, S., Peissel, B., Zaffaroni, D., Barile, M., Veil, A., Allavena, A., Dall’Olio, V., Peterlongo, P., Szabo, C.I., Zikan, M., Claes, K., Poppe, B., Foretova, L., Mai, P.L., Greene, M.H., Rennert, G., Lejbkowicz, F., Glendon, G., Ozcelik, H., Andrulis, I.L. for the Ontario Cancer Genetics Network, Thomassen, M., Gerdes, A-M., Sunde, L., Cruger, D., Jensen, U.B., Caligo, M., Friedman, E., Kaufman, B., Laitman, Y., Milgrom, R., Dubrovsky, M., Cohen, S., Borg, A., Jernström, H., Lindblom, A., Rantala, J., Stenmark-Askmalm, M., Melin, B. for SWE-BRCA, Nathanson, K., Domchek, S., Jakubowska, A., Lubinski, J., Huzarski, T., Osorio, A., Lasa, A., Durán, M., Tejada, M-I., Godino, J., Benitez, J., Hamann, U., Kriege, M., Hoogerbruge, N., van der Luijt, R.B., van Asperen, C.J., Devilee, P., Meijers-Heijboer, E.J., Blok, M.J., Aalfs, C.M., Hogervorst, F., Rookus, M. for HEBON, Cook, M., Oliver, C., Frost, D., Conroy, D., Evans, D.G., Lallo, F., Pichert, G., Davidson, R., Cole, T., Cook, J., Paterson, J., Hodgson, S., Morrison, P.J., Porteous, M.E., Walker, L., Kennedy, M.J., Dorkins, H., Peock, S. for EMBRACE, Godwin, A.K., Stoppa-Lyonnet, D., de Pauw, A., Mazoyer, S., Bonadona, V., Lasset, C., Dreyfus, H., Leroux, D., Hardouin, A., Berthet, P., Faivre, L. for GEMO, Loustalot, C., Noguchi, T., Sobol, H., Rouleau, E., Nogues, C., Frénay, M. Vénat-Bouvet, L. for GEMO, Hopper, J.L., Daly, M.B., Terry, M.B., John, E., Buys, S.S., Yassin, Y., Miron, A., Goldgar, D. for the Breast Cancer Family Registry, Singer, C.F., Dressler, A.C., Gschwantler-Kaulich, D., Pfeiler, G., Hanson, T.V.O., Jnson, L., Agnarsson, B.A., Kirchhoff, T., Offit, K., Devlin, V., Dutra-Clarke, A., Piedmonte, M., Rodriguez, G.C., Wakeley, K., Boggess, J.F., Basil, J., Schwartz, P.E., Blank, S.V., Toland, A.E., Montagna, M., Casella, C., Imyanitov, E., Tihomirova, L., Blanco, I., Lazaro, C., Ramus, S.J., Sucheston, L., Karlan, B.Y. Gross, J., Schmutzler, R., Wappenschmidt, B., Engel, C., Meindl, A., Lochman, M., Arnold, N., Heidemann, S., Varon-Mateeva, R., Niederacher, D., Sutter, C., Deissler, H., Gadzicki, D., Preisler-Adams, S., Kast, K., Schönbuchner, I., Caldes, T., de la Hoya, M., Aittomäki, K., Nevanlinna, H., Simard, J., Spurdle, A.B., Holland, H., Chen X. for kConFab, Platte, R., Chenevix-Trench, G., and Easton, D.F. on behalf of CIMBA.  “Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction,” Cancer Research 70(23):9742-9754, 2010 (PMCID: PMC2999830).
  • Miller, S.M., Roussi, P., Daly, M.B., Scarpato, J. “New Strategies in Ovarian Cancer: Uptake and Experience of Women at High Risk of Ovarian Cancer Who Are Considering Risk-Reducing Salpingo-Oophorectomy,” Clinical Cancer Research 16(21):5094-5106, 2010 (PMCID: PMC3107031).
  • Bevers, T.B., Armstrong, D.K., Arun, B., Carlson, R.W., Cowan, K.H., Daly, M.B., Fleming, I., Garber, J.E., Gemignani, M., Gradishar, W.J., Krontiras, H., Kulkarni, S., Laronga, C., Loftus, L., MacDonald, D.J., Mahoney, M.C., Merajver, S.D., Meszoely, I., Newman, L.  “Breast Cancer Risk Reduction – Clinical Practice Guidelines in Oncology,” JNCCN 8(10);1112-1146, 2010 (Not NIH funded).
  • Domchek, S.M., Friebel, T.M., Singer, C.F., Evans, D.G., Lynch, H.T., Isaacs, C., Garber, J.E., Neuhausen, S.L., Matloff, E., Eeles, R., Pichert, G., Van t’veer, L., Tung, N., Weitzel, J.N., Couch, F.J., Rubinstein, W.S., Ganz, P.A., Daly, M.B., Olopade, O.I., Tomlinson, G., Schildkraut, J., Blum, J.L., Rebbeck, T.R.  “Association of Risk-Reducing Surgery in BRCA1 and BRCA2 Mutation Carriers with Cancer Risk and Mortality,” JAMA 304(9):967-975, 2010. (PMCID: PMC2948529).
  • Bradbury, A.R., Patrick-Miller, L., Egleston, B., Sands, C.B., Li, T., Schmidheiser, H., Feigon, M., Ibe, C.N., Hlubocky, F.J., Hope, K., Jackson, S., Corbman, M., Olopade, O.I., Daly, M., Daugherty, C.K.  “Parent Opinions Regarding the Genetic Testing of Minors for BRCA1/2,” J. Clin. Oncol. 28(21):3498-3505, 2010 (Not NIH funded).
  • Daly, M.B., Axilbund, J.E., Buys,S., Crawford, B., Farrell, C.D., Friedman, S., Garber, J.E., Goorha, S., Gruber, S.B., Hampel, H., Kaklamani, V., Kohlmann, W., Kurian, A., Litton, J., Marcom, P.K., Nussbaum, R., Offit, K., Pal, T., Pasche, B., Pilarski, R., Reiser, G., Shannon, K.M., Smith, J.R., Swisher,E., Weitzel, J.N.  “Genetic/Familial High-Risk Assessment: Breast and Ovarian,” JNCCN 8(5):562-594, 2010.  (Not NIH funded).
  • Daly, M.B.  “Oophorectomy as a Preventative Measure for Ovarian Cancer,” Therapy 7(3):241-247, 2010.  (Not NIH funded).
  • Roussi, P., Sherman, K.A., Miller, S., Buzaglo, J., Daly, M., Taylor, A., Ross, E., Godwin, A.  “Enhanced Counseling for Women Undergoing BRCA1/2 Testing: Impact on Knowledge and Psychological Distress – Results from a Randomised Clinical Trial,” Psychol Health 25(4):401-415, 2010.  (PMCID: PMC2866521)
  • Domchek, S.M., Friebel, T.M., Garber, J.E., Isaacs, C., Matloff, E., Eeles, R., Evans, D.G., Rubinstein, W., Singer, C.F., Rubin, S., Lynch, H.T., Daly, M.B., Weitzel, J., Ganz, P.A., Pichert, G., Olopade, OI, Tomlinson, G., Tung, N., Blum, J.L., Couch, F., Rebbeck, T.R.  “Occult Ovarian Cancers Identified at Risk-Reducing Salpingo-Oophorectomy in a Prospective Cohort of BRCA1/2 Mutation Carriers, “ Breast Cancer Res Treat 124(1):195-203, 2010 (PMCID: PMC2949487).
  • Petrucelli, N., Daly, M.B., Feldman, G.L.  “Hereditary Breast and Ovarian Cancer Due to Mutations in BRCA1 and BRCA2,” Genet Med 12(5):245-259, 2010. (Review). (Not NIH funded).
  • Bellacosa, A., Godwin, A.K., Peri, S., Devarajan, K., Caretti, E., Vanderveer, L., Bove, B., Slater, C., Zhou, Y., Daly, M., Howard, S., Campbell, K.S., Nicolas, E., Yeung, A.T., Clapper, M.L., Crowell, J.A., Lynch, H.T., Ross, E., Kopelovich, L., Knudson, A.G.  “Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of BRCA1 and BRCA2 Mutations, “ Cancer Prev Res 3(1):48-61, 2010. (PMCID: PMC2804937).
Top

2009

  • Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Heerdt AS, Helvie M, Huff JG, Khakpour N, Khan SA, rontiras H, Lyman G, Rafferty E, Shaw S, Smith ML, Tsangaris TN, Williams C, Yaneeklov T. Breast Cancer Screening and Diagnosis. JNCCN. 2009;7(10):1060-96. (Not funded by NIH).
  • Neuhausen SL, Brummel S, Ding YC, Singer CF, Pfeiler G, Lynch HT, Nathanson KL, Rebbeck TR, Garber JE, Couch F, Weitzel J, Narod SA, Ganz PA, Daly MB, Godwin AK, Isaacs C, Olopade OI, Tomlinson G, Rubinstein WS, Tung N, Blum JL, Gillen DL. Genetic Variation in Insulin-Like Growth Factor Signaling Genes and Breast Cancer Risk Among BRCA1 and BRCA2 Carriers. Breast Cancer Res. 2009;11(5):R76.
  • Saetrom P, Biesinger J, Li SM, Smith D, Thomas LF, Majzoub K, Rivas GE, Alluin J, Rossi JJ, Krontiris TG, Weitzel J, Daly MB, Benson AB, Kirkwood JM, O'Dwyer PJ, Sutphen R, Stewart JA, Johnson D, Larson GP. A Risk Variant in an miR-125b Binding Site in BMPR1B is Associated with Breast Cancer Pathogenesis. Cancer Res. 2009 Sep 15;69(18):7459-65.
  • Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S; KConFab, Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Weerasooriya N; OCGN, Gerdes AM, Thomassen M, Cruger DG, Caligo MA, Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E, Jernström H, Askmalm MS, Arver B, Malmer B; SWE-BRCA, Domchek SM, Nathanson KL, Brunet J, Ramón Y Cajal T, Yannoukakos D, Hamann U; HEBON, Hogervorst FB, Verhoef S, Gómez García EB, Wijnen JT, van den Ouweland A; EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Cook J, Hodgson S, Morrison PJ, Douglas F, Godwin AK; GEMO, Sinilnikova OM, Barjhoux L, Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Révillion F, Peyrat JP, Muller D, Fricker JP, Lynch HT, John EM, Buys S, Daly M, Hopper JL, Terry MB, Miron A, Yassin Y, Goldgar D; Breast Cancer Family Registry, Singer CF, Gschwantler-Kaulich D, Pfeiler G, Spiess AC, Hansen TV, Johannsson OT, Kirchhoff T, Offit K, Kosarin K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Varon-Mateeva R, Schaefer D, Froster UG, Caldes T, de la Hoya M, McGuffog L, Antoniou AC, Nevanlinna H, Radice P, Benítez J.  Evaluation of a Candidate Breast Cancer Associated SNP in ERCC4 as a Risk Modifier in BRCA1 and BRCA2 Mutation Carriers. Results from The Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).  British Journal of Cancer. 2009;101(12):2048-54.
  • Vig HS, Armstrong J, Egleston BL, Mazar C, Toscano M, Bradbury AR, Daly MB, Meropol NJ. Cancer Genetic Risk Assessment and Referral Patterns in Primary Care. Genetic Testing and Molecular Biomarkers, 2009;13(6):735-41.
  • Rebbeck TR, Mitra N, Domchek SM, Wan F, Chuai S, Friebel TM, Panossian S, Spurdle A, Chenevix-Trench G; kConFab, Singer CF, Pfeiler G, Neuhausen SL, Lynch HT, Garber JE, Weitzel JN, Isaacs C, Couch F, Narod SA, Rubinstein WS, Tomlinson GE, Ganz PA, Olopade OI, Tung N, Blum JL, Greenberg R, Nathanson KL, Daly MB. Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers. Cancer Res. 2009;69:5801-10.
  • Whittemore AS, Stearman B, Venne V, Halpern J, Felberg A, McGuire V, Daly M, Buys SS. No Evidence of Familial Correlation in Breast Cancer Metastasis. Breast Cancer Res. Treat. 2009;118(3):575-81.
  • Huo D, Senie RT, Daly M, Buys SS, Cummings S, Ogutha J, Hope K, Olopade OI. Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States. Journal of Clinical Oncology. 2009;27(8):1184-90.
  • Apicella C, Peacock SJ, Andrews L, Tucker K, Daly MB, Hopper JL. Measuring, and identifying predictors of, women's perceptions of three types of breast cancer risk: population risk, absolute risk and comparative risk. Br J Cancer. 2009 Feb;100(4):583-9.
  • Fang CY, Cherry C, Devarajan K, Li TY, Malick J, Daly MB. A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol. 2009 Mar;112(3):594-600.
  • Daly MB. The impact of social roles on the experience of men in BRCA1/2 families: implications for counseling. J Genet Couns. 2009 Feb;18(1):42-8.
  • Neuhausen SL, Ozcelik H, Southey MC, John EM, Godwin AK, Chung W, Iriondo-Perez J, Miron A, Santella RM, Whittemore A, Andrulis IL, Buys SS, Daly MB, Hopper JL, Seminara D, Senie RT, Terry MB; Breast Cancer Family Registry. BRCA1 and BRCA2 Mutation Carriers in the Breast Cancer Family Registry: an Open Resource for Collaborative Research,” Breast Cancer Res Treat. 2009 Jul;116(2):379-86.
Top

2008

  • Eisen A, Lubinski J, Gronwald J, Moller P, Lynch HT, Klijn J, Kim-Sing C, Neuhausen SL, Gilbert L, Ghadirian P, Manoukian S, Rennert G, Friedman E, Isaacs C, Rosen E, Rosen B, Daly M, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers, J Natl Cancer Inst. 2008;100(19):1341-3.
  • Ding Y, Larson G, Rivas G, Lundberg C, Geller L, Ouyang C, Weitzel J, Archambeau J, Slater J, Daly MB, Benson AB, Kirkwood JM, O'Dwyer PJ, Sutphen R, Stewart JA, Johnson D, Nordborg M, Krontiris TG. “Strong Signature of Natural Selection within an FHIT Intron Implicated in Prostate Cancer Risk. PLoS ONE. 2008;3(10):e3533.
  • Tseng M, Olufade T, Kurzer MS, Wahala K, Fang CY, van der Schouw YT, Daly MB. Food Frequency Questionnaires and Overnight Urines Are Valid Indicators of Daidzein and Genistein Intake in US Women Relative to Multiple 24-h Urine Samples. Nutrition and Cancer-an International Journal. 2008 Sep-Oct;60(5):619-26.
  • Barsevick AM, Montgomery SV, Ruth K, Ross EA, Egleston BL, Bingler R, Malick J, Miller SM, Cescon TP, Daly MB. Intention to communicate BRCA1/BRCA2 genetic test results to the family. J Fam Psychol. 2008 Apr;22(2):303-12.
  • Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch H, Eeles RA, Neuhausen SL, Daly MB, Matloff E, Blum JL, Sabbatini P, Barakat RR, Hudis C, Norton L, Offit K, Rebbeck TR. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: A multicenter, prospective study. J Clin Oncol. 2008 Mar;26(8):1331-7.
  • Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deissler H, Caldes T, Kampjarvi K, Nevanlinna H, Simard J, Beesley J, Chen XQ, Neuhausen SL, Rebbeck TR, Wagner T, Lynch HT, Isaacs C, Weitzel J, Ganz PA, Daly MB, Tomlinson G, Olopade OI, Bium JL, Couch FJ, Peterlongo P, Manoukian S, Barile M, Radice P, Szabo CI, Pereira LH, Greene MH, Rennert G, Leibkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Gerdes AM, Caligo MA, Laitman Y, Kaufman B, Milgrom R, Friedman E, Domchek SM, Nathanson KL, Osorio A, Llort G, Milne RL, Benitez J, Hamann U, Hogervorst FB, Manders P, Ligtenberg MJ, van den Ouweland AM, Peock S, Cook M, Platte R, Evans DG, Eeles R, Pichert G, Chu C, Eccles D, Davidson R, Douglas F, Godwin AK, Barjhoux L, Mazoyer S, Sobol H, Bourdon V, Eisinger F, Chompret A, Capoulade C, Paillerets BB, Lenoir GM, Gauthier-Villars M, Houdayer C, Stoppa-Lyonnet D, Easton DF. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet. 2008 Apr;82(4):937-48.
  • Chen X, Weaver J, Bove BA, Vanderveer LA, Weil SC, Miron A, Daly MB, Godwin AK. Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk. Hum Mol Genet. 2008 May 1;17(9):1336-48.
  • Masny A, Ropka ME, Peterson C, Fetzer D, Daly MB. Mentoring nurses in familial cancer risk assessment and counseling: lessons learned from a formative evaluation. J Genet Couns. 2008 Apr;17(2):196-207.
  • Breast Cancer Family Registry, Kathleen Cuningham Consortium for Research into Familial Breast Cancer (Australasia), Ontario Cancer Genetics Network (Canada). Smoking and Risk of Breast Cancer in Carriers of Mutations in BRCA1 or BRCA2 aged less than 50 years. Breast Cancer Res Treat 109(1):67-75, 2008. (Accepted prior to April 7, 2008).
Top

2007

  • Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. Clinical Breast Cancer. 2007 Dec;7(11):875-82.
  • Tseng M, Byrne C, Evers KA, Daly MB. Dietary intake and breast density in high-risk women: a cross-sectional study. Breast Cancer Res. 2007;9(5):R72.
  • Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Lawton T, Loftus L, Macdonald DJ, Mahoney MC, Merajver SD, Seewaldt V, Sellin RV, Shapiro CL, Singletary E, Ward JH. "Breast Cancer Risk Reduction” J Natl Compr Can Netw. 200;5(8):676-701..
  • Bell DW, Kim SH, Godwin AK, Schiripo TA, Harris PL, Haserlat SM, Wahrer DC, Haiman CA, Daly MB, Niendorf KB, Smith MR, Sgroi DC, Garber JE, Olopade OI, Le Marchand L, Henderson BE, Altshuler D, Haber DA, Freedman ML. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer. 2007 Dec;121(12):2661-7.
  • Tchou J, Ward MR, Volpe P, Palma MD, Medina CA, Sargen M, Sonnad SS, Godwin AK, Daly M, Winchester DJ, Garber J, Weber BL, Domchek S, Nathanson KL. Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States. Clinical Breast Cancer. 2007 Jun;7(8):627-33.
  • Apicella C, Dowty JG, Dite GS, Jenkins MA, Senle RT, Daly MB, Andrulis IL, John EM, Buys SS, Li FP, Glendon G, Chung W, Ozcelik H, Miron A, Kotar K, Southey MC, Foulkes WD, Hopper JL. Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish women. Clin Genet. 2007 Aug;72(2):87-97.
  • Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, Porteous ME, Jakubowska A, Lubinski J, Gronwald J, Spurdle AB, KconFab, Schmutzler R, Versmold B, Engel C, Meindl A, Sutter C, Horst J, Schaefer D, Offit K, Kirchhoff T, Andrulis IL, Ilyushik E, Glendon G, Devilee P, Vreeswijk MP, Vasen HF, Borg A, Backenhorn K, Struewing JP, Greene MH, Neuhausen SL, Rebbeck TR, Nathanson K, Domchek S, Wagner T, Garber JE, Szabo C, Zikan M, Foretova L, Olson JE, Sellers TA, Lindor N, Ll HN, Tommiska J, Aittomaki K, Hamann U, Rashid MU, Torres D, Simard J, Durocher F, Guenard F, Lynch HT, Isaacs C, Weitzel J, Olopade OI, Narod S, Daly MB, Godwin AK, Tomlinson G, Easton DF, Chenevix-Trench G, Antoniou AC. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiology Biomarkers & Prevention. 2007 Jul;16(7):1416-21.
  • Sauter ER, Ganz PA, Ehya H, Hewett JE, Schlatter L, Kliethermes B, Daly MB. Prospective multicenter trial to determine the feasibility of collection and predictive ability of breast fluid analysis in postmenopausal women receiving SERMs. Breast. 2007 Oct;16(5):489-94.
  • Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, Domchek S, Randall S, Karlan B, Zhang P, Zhang SY, Sun P, Narod SA. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiology Biomarkers & Prevention. 2007 May;16(5):912-6.
  • Terry MB, Knight JA, Zablotska L, Wang Q, John EM, Andrulis IL, Senie RT, Daly M, Ozcelik H, Briollais L, Santella RM. Alcohol metabolism, alcohol intake, and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry. Breast Cancer Res Treat. 2007 Dec;106(2):281-8.
  • Kotsopoulos J, Lubinski J, Lynch HT, Klijn J, Ghadirian P, Neuhausen SL, Kim-Sing C, Foulkes WD, Moller P, Isaacs C, Domchek S, Randall S, Offit K, Tung N, Ainsworth P, Gershoni-Baruch R, Eisen A, Daly M, Karlan B, Saal HM, Couch F, Pasini B, Wagner T, Friedman E, Rennert G, Eng C, Weitzel J, Sun P, Narod SA; The Hereditary Breast Cancer Clinical Study Group. Age at First Birth and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Breast Cancer Res Treat. 2007 Oct;105(2):221-8.
  • Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB, Giles G, Godwin AK, Hibshoosh H, Hopper JL, John EM, Layfield L, Longacre T, Miron A, Senie R, Southey MC, West DW, Whittemore AS, Wu H, Andrulis IL, O'Malley FP. BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Am J Surg Pathol. 2007 Jan;31(1):121-8.
Top

2006

  • Daly MB. Tamoxifen in Ductal Carcinoma in Situ. Semin Oncol. 2006;33:647-9.
  • Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, Isaacs C, Weber B, Foulkes WD, Moller P, Rosen B, Kim-Sing C, Gershoni-Baruch R, Ainsworth P, Daly M, Tung N, Eisen A, Olopade OI, Karlan B, Saal HM, Garber JE, Rennert G, Gilchrist D, Eng C, Offit K, Osborne M, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Spontaneous and Therapeutic Abortions and the Risk of Breast Cancer Among BRCA Mutation Carriers,” Breast Cancer Res. 2006;8(2):R15.
  • Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. “Tamoxifen and Contralateral Breast Cancer in BRCA1 and BRCA2 carriers: An Update. Int J Cancer. 2006 May 1;118(9):2281-4.
  • Milne RL, Daly MB, Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, Southey M, West DW. Hopper JL, Whittemore AS, kConFab Investigators. No Increased Risk of Breast Cancer Associated with Alcohol Consumption Among Carriers of BRCA1 and BRCA2 Mutations Ages <50 Years. Cancer Epidemiol Biomarkers Prev. 2006;15:1565-7.
  • Peacock S, Apicella C, Andrews L, Tucker K, Bankier A, Daly MB, Hopper JL A Discrete Choice Experiment of Preferences for Genetic Counseling Among Jewish Women Seeking Cancer Genetics Services. Br J Cancer. 2006;95:1448-53.
  • Fang CY, Daly MB, Miller SM, Zerr T, Malick J, Engstrom P. Coping with Ovarian Cancer Risk: The Moderating Effects of Perceived Control on Coping and Adjustment. British Journal of Health Psychology. 2006;11:561-80.
  • Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MR, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC; kConFab Investigators; Ontario Cancer Genetics Network Investigators, Whittemore AS. “BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50,” Cancer Epidemiol Biomarkers Prev. 2006;15(10):1863-70.
  • McGuire V, John EM, Felberg A, Haile RW, Boyd NF, Thomas DC, Jenkins MA, Milne RL, Daly MB, Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, Southey M, West DW, Hopper JL, Whittemore AS; kConFab Investigators. No Increased Risk of Breast Cancer Associated with Alcohol Consumption Among Carriers of BRCA1 and BRCA2 Mutations ages <50 Years. Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1565-7.
  • Cai KQ, Klein-Szanto A, Karthik D, Edelson M, Daly MB, Ozols RF, Lynch HT, Godwin AK, Xu XX. Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations. Gynecol Oncol. 2006 Nov;103(2):719-28.
  • Bevers TD, Anderson BO, Bonaccio E, Borgen PI, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Helvie M, Hoover S, Krontiras H, Shaw S, Singletary E, Sugg Skinner C, Smith ML, Tsangaris TN, Wiley EL, Williams C. Breast Cancer Screening and Diagnosis. J Natl Compr Canc Netw. 2006;4(5):480-508,.
  • Tseng M, Byrne C, Evers KA, London WT, Daly MB. Acculturation and breast density in foreign-born, u.s. Chinese women. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1301-5.
  • Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P, Narod SA. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 2006;296:185-92.
  • Daly MB, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Ford JM, Garber JE, Jeter JM, Kohlmann W, Lynch PM, Marcom PK, Nabell LM, Offit K, Osarogiagbon RU, Pasche B, Reiser G, Sutphen R, Weitzel JN, National Comprehensive Cancer N. Genetic/familial high-risk assessment: breast and ovarian. Journal of the National Comprehensive Cancer Network. 2006 Feb;4(2):156-76.
  • Spurdle AB, Antoniou AC, Kelemen L, Holland H, Peock S, Cook MR, Smith PL, Greene MH, Simard J, Plourde M, Southey MC, Godwin AK, Beck J, Miron A, Daly MB, Santella RM, Hopper JL, John EM, Andrulis IL, Durocher F, Struewing JP, Easton DF, Chenevix-Trench G. The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology Biomarkers & Prevention. 2006 Jan;15(1):76-9.
  • Chen X, Truong TT, Weaver J, Bove BA, Cattie K, Armstrong BA, Daly MB, Godwin AK. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Hum Mutat. 2006 Apr 17;27(5):427-35.
  • Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C, Garber JE, Daly M, Eeles R, Matloff E, Tomlinson GE, Van't Veer L, Lynch HT, Olopade O, Weber BL, Rebbeck TR. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. LANCET ONCOLOGY. 2006 Mar;7(3):223-9.
  • Colilla S, Kantoff PW, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Brown M, Weber BL, Rebbeck TR. The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis. 2006 Mar;27(3):599-605.
Top